Partner With Us NRI

Company details

6M Return -19.79%
1Y Return -3.34%
Mkt Cap.(Cr) 7,484.61
Volume 41,375
Div Yield 1.06%
OI Chg %
Volume 41,375

Open Free Demat Account Online with ICICIDIRECT


  • swot

  • technicals

  • deals

  • shareholding


Delivery and volume


  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio


Operating Profit(Cr.)

Profit after Tax(Cr.)


Reserves and Surplus



Operating Profit

Profit after tax





Equity Capital: 1,922.94 Cr FV: 1.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 23,081.38 -37,247.74
LAST 3M 71,111.08 -54,074.79
LAST 6M 141,746.37 -188,969.09
LAST 12M 212,995.89 -183,256.64
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
Feb 10, 2022 Dividend 250
Aug 05, 2021 Dividend 35


  • About Company
  • Company Info
  • Listing Info
  • Jubilant Ingrevia Limited is a public limited company incorporated on 23 October 2019 under provisions of Companies Act, 2013 in Uttar Pradesh. The name of Company was changed from its initial name of `Jubilant LSI Limited` to `Jubilant Ingrevia Limited` through Certificate of Incorporation w.e.f. 16 October 2020. The shares of the company were listed on BSE and NSE Limited effective from 19 March 2021. The Company is a global integrated life science products and innovative solutions provider serving, pharmaceutical, nutrition, agrochemical, consumer and industrial customers with its customised products and solutions that are innovative, cost effective and conforming to premium quality standards. It is engaged in manufacturing and supply of speciality intermediates, nutrition & health solutions and life science chemicals through five manufacturing facilities in India. It offers broad portfolio of high quality ingredient that find application in a wide range of industries. It serves more than 1400 customers in more than 60 countries across the world. The portfolio of the company is extended to custom research and manufacturing for pharmaceutical and agrochemical customers. The Board of Directors of Company in their meeting held on 24 October 2019 had approved the Composite Scheme of Arrangement for amalgamation of certain promoter controlled entities into Jubilant Pharmova Limited (JPM), the Demerged Company and demerger of Life Science Ingredients business into the Company, which was subsequently filed with National Company Law Tribunal (NCLT). The Composite Scheme was approved by Honourable NCLT, Allahabad Bench vide its order dated 23 December 2020. The Said NCLT Order was filed with the Registrar of Companies (ROC) by the Company and the Demerged Company on 01 February 2021 thereby making Composite Scheme effective. In terms of Composite Scheme, all assets and liabilities of LSI business of the Demerged Company were transferred and vested into the Company on 1 February 2021, being the Demerger Appointed Date. Accounting of transfer of LSI business as per approved Composite Scheme were as follows: 1) The assets and liabilities pertaining to the LSI business, transferred to and vested in the Company pursuant to the Composite Scheme are recorded at their respective carrying values as appearing in books of the Demerged Company. 2) The Company issued 159,281,139 fully paid-up equity shares of Re 1/- each to shareholders of the Demerged Company, for every one fully paid-up equity share of Re 1 each held by them in the Demerged Company for consideration other than cash. 3) The pre-demerger shareholding of Demerged Company in the Company comprising of 500,000 fully paid-up equity shares of Re 1/- each was cancelled. 4) The share capital account has been credited with aggregate face value of shares issued to shareholders pursuant to Composite Scheme and difference has been accounted in appropriate reserves within "Other equity". Pursuant to Composite Scheme of Arrangement, five subsidiary companies of Jubilant Pharmova Limited namely, Jubilant Infrastructure Limited, Jubilant Life Sciences (USA) Inc., Jubilant Life Sciences International Pte. Limited, Jubilant Life Sciences (Shanghai) Limited and Jubilant Life Sciences NV became subsidiaries of the Company effective from February 1, 2021. Demerger of the LSI business of Jubilant Pharmova Limited pursuant to the Scheme became effective from February 1, 2021. Consequently, the LSI business has been demerged into the Company. As on Demerger Record date i.e., on 05 February 2021, the Investors Education and Protection Fund (IEPF) Authority was holding 1,979,743 equity shares of Jubilant Pharmova Limited, (the demerged company). Accordingly, IEPF Authority was allotted 1,979,743 equity shares of the Company. On 2 June 2021, Jubilant Crop Protection Limited Company was incorporated as a wholly owned subsidiary of the company with a paid-up capital of Rs 1 lakh to carry on the business in manufacturing of Pesticides/plant protection chemicals. During the year 2021, Jubilant Ingrevia has acquired 2,657 0.01% Convertible Preference Shares (CPS) of Rs 10/- each of Mister Veg Foods Private Limited, India (MVFPL), for a consideration of Rs 21.64 million, representing potential 20.99% shareholding in MVFPL, once converted. CPS are convertible into equity Shares of MVFPL at a defined conversion ratio as per the terms of the underlying contract. In FY 2022, the company is planning to expand the product portfolio of alcohols and forward integrate anhydride into a basket of value-added products to cater the need of existing and new customers as well.

Read More

Registered Address

Bhartiagram, Gajraula, Amroha, Uttar Pradesh, 244223

Tel : 91-120-4361000
Email : deepanjali.gulati:jubl.com
Website : http://www.jubilantingrevia.com


Alankit Assignments Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 543271
Book Closure Date (Month) :
BSE Group : A
ISIN : INE0BY001018

ICICIdirect Jubilant Ingrevia Ltd FAQ

You can buy Jubilant Ingrevia Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Jubilant Ingrevia Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 27, 2022 04:01 PM the closing price of Jubilant Ingrevia Ltd was ₹ 469.90.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 27, 2022 04:01 PM, the market cap of Jubilant Ingrevia Ltd stood at ₹ 7,484.61.
The latest PE ratio of Jubilant Ingrevia Ltd as of May 27, 2022 04:01 PM is 15.66
The latest PB ratio of Jubilant Ingrevia Ltd as of May 27, 2022 04:01 PM is 0.33
The 52-week high of Jubilant Ingrevia Ltd is ₹ 877.95 while the 52-week low is ₹ 401.35 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote